Current Profile

Keryx Biopharmaceuticals (Inactive Symbol)

YTD Price Probability

No random walk data for 2024

Default prediction by Z-Score (what's this?).

Z Score :

-4.3224

Sector

Industry

View the other companies in the same industry : Bio Therapeutic Drugs

Alternative Z-Scores designed for non-public companies (i.e. take these with a grain of salt):

For manufacuring companies:

Z' Score :

-2.2682

Sector Industry

For non-manufacturing companies:

Z'' Score :

-9.2274

Sector Industry

Fundamental Analysis metrics & ratios (what's this?).

Date of financial statements used: 2017-03-31
Book Value:	$-25.7M	Internal Value:	$-25.7M	Working Capital:	$97.2M
Debt to Asset Ratio:	1.176	Current Ratio:	5.394	Turnover Ratio:	3.755
Net Margin:	-194.8%	EPS:	-0.869	P/E ratio:	-7.526
P/B ratio:	-26.917	ROE:	357.9%	ROA:	-72.1%

Symbol: KERX

Market Cap: $692.6M

Exchange: NASDAQ

Data Since: 2001-01-02